The timing of EPO administration was immediately after induced coronary thrombosis in animal studies; EPO doses ranged from 2,500 to 5,000 IU per kg in rats versus 430-860 IU per kg in humans [6]. The gene discussed is EPO; the disease is Venous thrombosis.